Results 211 to 220 of about 50,141 (259)

Effect of spironolactone on monocyte subsets in atrial fibrillation: IMPRESS-AF randomised controlled trial. [PDF]

Sci Rep
Shahid F, Shantsila E, Shantsila A, Lip GYH.   +3 more
europepmc   +1 more source

In patients with heart failure and reduced ejection fraction, should all treatments (such as beta-blockers, ACE inhibitors, sacubitril-valsartan, gliflozins, and spironolactone) be started simultaneously, or is a gradual and staggered introduction recommended?

Tripdatabase
openalex   +1 more source

The Impact of Cirrhosis Severity and Spironolactone on Sex Hormone Levels in Men. [PDF]

Gastro Hep Adv
Akin Belli A, Flikshteyn B, Ziv Y, Lu A, Luo G, Lebovics N, Sigal SH.   +6 more
europepmc   +1 more source

Human and zebrafish mineralocorticoid receptors reporter cell assays to assess the activity of chemicals. [PDF]

iScience
Toso A, Boulahtouf A, Grimaldi M, Sansaloni A, Katsu Y, Baker ME, Escande A, Garoche C, Aït-Aïssa S, Balaguer P.   +9 more
europepmc   +1 more source

Spironolactone as an alternative way of treating acne in women - review

Magdalena Gajkiewicz, Radosław Zaucha, Zuzanna Felińska, Tomasz Fura, Julia Silldorff, Marcin Dudek, M Zajac, Oliwia Iszczuk, Stanisław Anczyk   +8 more
openalex   +2 more sources

Efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a meta-analysis of randomized controlled trials. [PDF]

BMC Cardiovasc Disord
Wu J, Pei Y, Wu J, Huang Y.
europepmc   +1 more source

Sodium zirconium cyclosilicate, hyperkalaemia, and spironolactone optimization in heart failure with reduced ejection fraction: The REALIZE-K open-label run-in phase. [PDF]

Eur J Heart Fail
Petrie MC, Cherney DZI, Desai AS, Testani JM, Verma S, Chinnakondepalli K, Dolling D, Patel S, Dahl M, Eudicone JM, Friberg L, Ouwens M, Antunes MO, Connelly KA, Madrini V, Kuthi L, Lala A, Lorenzo M, Guimarães PO, Cobo Marcos M, Merkely B, Gonzales-Calle D, Nuñez Villota J, Squire I, Václavík J, Wranicz J, Kosiborod MN.   +26 more
europepmc   +1 more source

Correction: Clinical evaluation of a novel fixed-dose combination tablet (Sentorpil^® ForteGold) versus compounded powdered medications in dogs with myxomatous mitral valve disease: a randomized, double-blind study. [PDF]

Front Vet Sci
Park J, Lee J, Lee SJ, Hyun C.
europepmc   +1 more source

Use of Spironolactone for the Treatment of Heart Failure With Preserved Ejection Fraction: Efficacy and Clinical Implications in Light of Recent Evidence. [PDF]

Cureus
Maharjan R, Akintunde DM, Reddy Narla SJS, Baltodano Garcia DC, Mekala SC, Srinivasan S, Nath TS.   +6 more
europepmc   +1 more source